US Patent Issued to Abbott Diabetes Care on Sept. 8 for "Model based variable risk false glucose threshold alarm prevention mechanism" (California Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,727,833, issued on Sept. 8, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Model based variable risk false glucose threshold alarm prevention mechanism" was invented by Erwin Satrya Budiman (Fremont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of determining when to activate an analyte, e.g. glucose, related alarm, such as a hypoglycemia alarm, of a continuous analyte monitor is provided. Also provided are systems, devices and kits."

The patent was filed on Aug. 8, 2022, under Application No. 17/882,860.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Pars...